OTWorld 2024 - Heartfelt thank you 💜 As OTWorld - International Trade Show & World Congress wraps up, we want to shout out a HUGE thank you to everyone who stopped by, had insightful discussions, and shared their passion for orthopedic innovation with us! 🦾 Since the Qwadra merger last March, your unwavering commitment has touched our hearts deeply. Your enthusiasm and support fuel our drive every single day ! We’re beyond inspired by the connections made and we'd like to thank you for trusting us and being part of our journey to revolutionize orthopedic care. 🫶🏼 Let’s keep collaborating, innovating, and making a difference together. Until next time! (see you soon...👀) If you want to know more, please feel free to contact us at info@qwadra.com 📧 #tradefair #rodin4d #techmed3d #vorum #oandp #otworld24
TechMed 3D’s Post
More Relevant Posts
-
APT Medical (SHSE: 688617), a portfolio company of Qiming Venture Partners, has received approval for the launch of its Detachcoil™ Peripheral Detachable Spring Coil. This innovative product features a soft platinum-tungsten alloy, providing excellent imaging clarity and MRI compatibility. Its dense cilia promote rapid thrombosis formation for efficient vascular occlusion. The coil's unique interlocking arms allow for controlled release, with the option for repositioning or retraction before full deployment. Available in multiple sizes, including 0.018" and 0.035", the Detachcoil™ offers a versatile solution. #MedicalInnovation #VascularIntervention #HealthcareTechnology #MedicalDevices #MedicalBreakthrough #MRICompatible #Thrombosis #QimingPortfolio #QimingHealthcare
-
-
Vision Correction Surgeon| Founder & Director OCL Vision| Consultant Eye Surgeon Moorfields Eye Hospital
EndoArt update 1 month post-op: Further air injection required at 2 weeks due to inferior detachment. At 1 month, unaided VA 6/24 improving to 6/12 with pinhole. EndoArt attached with a clear cornea and good resolution of corneal edema centrally. #Endoart #innovation #artificialcornea OCL Vision
-
-
Here’s another example of how we collaborate with our clients to be Successful Together. Check out this video that features our work with #client Miach Orthopaedics, Inc. to refresh their brand and launch the groundbreaking #BEARImplant for #ACLtears. #SuccessfulTogether #Casestudy #Healthcarecommunications #Healthcaremarketing Joni Ramirez Joyce Ip Chad Garbarini
-
Check out what experts had to say on how Johnson & Johnson MedTech Orthopaedics is redefining partial knee arthroplasty. Learn more about rUKA with VELYS™ Robotic-Assisted Solution here: https://bit.ly/4iBCgir. #mycompany
-
Contact Lenses Market Worth $10.2 billion by 2025 ☑️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:https://lnkd.in/dXPFYYQN The size of global contact lenses market in terms of revenue was estimated to be worth $7.4 billion in 2020 and is poised to reach $10.2 billion by 2025, growing at a CAGR of 6.7% from 2020 to 2025. 🔵𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Johnson & Johnson (US), CooperVision (US), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), and Hoya Corporation (Japan). 🔵𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Bausch + Lomb CooperVision STAAR Surgical CooperCompanies CIBA Vision Charlotte Eye Ear Nose & Throat Associates, P.A. (CEENTA) CooperVision Specialty Americas Thomas Eye Group TLC Laser Eye Centers Visibly Mazak Europe Eye Health America SynergEyes, Inc. Dr. Tavel Optical Group Hubble Contacts Optical Express Bausch + Lomb Ireland Houston Eye Associates Mediphacos KOCH Pac-Systeme GmbH Sky Optical LLC Famacy Glass CooperVision Specialty EyeCare EMEA Menicon Oculus Private Limited Eye Consultants of Atlanta Sharif Eye Centers Memira
-
-
Exciting News! The Lumohs Lighted Scalpel Handles are back in stock after flying off the shelves due to high demand! These must-have dissection tools are essential for anatomy and forensic pathology professionals. The Lumohs Scalpel Handle provides precise, shadowless illumination just millimeters from your specimen, ensuring clear visibility during dissections and autopsies. This reusable, autoclavable device is perfect for areas where overhead lighting falls short. Why choose Lumohs? Versatile Compatibility: Works with any blade size or brand, and is available in sizes No. 3, No. 4, and No. 8. Reusable and Durable: Autoclavable like any standard instrument, ensuring long-lasting use. Ergonomic Design: The wide round grip minimizes hand strain and fatigue, facilitating easy rotation while cutting. Precision Lighting: Delivers unobstructed illumination in areas such as the perineum, genitalia, ears, and scalp. Enhanced Visibility: Improves visualization when working near nerves and vessels in anatomically sensitive areas. Reduced Physical Strain: Alleviates neck, back, and wrist fatigue by providing optimal lighting and reducing the need for awkward positioning. Elevate your precision and comfort with the Lumohs Lighted Scalpel Handle—now available in all sizes! Learn more at mortechmfg.com/lumohs #forensicpathology #anatomy #mortechmanufacturing #lumohs
-
🧐 Did you know CONTOURA® Vision can help your patients see better with a 5.2% decrease in light sensitivity?¹* Improve comfort and clarity beyond glasses and contacts. 💪 Empower your practice with advanced care and see the difference CONTOURA® Vision can make. Explore now: https://lnkd.in/dAVUdngA #wavelight #AlconUSA #LASIK #ContouraVision *When compared to the baseline, Contoura® Vision improved symptoms typically associated with wearing glasses and contact lenses. 1.Stulting RD, Fant BS; T-CAT Study Group. Results of topography-guided laser in situ keratomileusis custom ablation treatment with a refractive excimer laser. J Cataract Refract Surg. 2016;42(1):11-18.
-
-
Contact Lenses Market Worth $10.2 billion by 2025 ☑️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:https://lnkd.in/dXPFYYQN The size of global contact lenses market in terms of revenue was estimated to be worth $7.4 billion in 2020 and is poised to reach $10.2 billion by 2025, growing at a CAGR of 6.7% from 2020 to 2025. 🔵𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Johnson & Johnson (US), CooperVision (US), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), and Hoya Corporation (Japan). 🔵𝐎𝐭𝐡𝐞𝐫 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Bausch + Lomb CooperVision STAAR Surgical CooperCompanies CIBA Vision Charlotte Eye Ear Nose & Throat Associates, P.A. (CEENTA) CooperVision Specialty Americas Thomas Eye Group TLC Laser Eye Centers Visibly Mazak Europe Eye Health America SynergEyes, Inc. Dr. Tavel Optical Group Hubble Contacts Optical Express Bausch + Lomb Ireland Houston Eye Associates Mediphacos KOCH Pac-Systeme GmbH Sky Optical LLC Famacy Glass CooperVision Specialty EyeCare EMEA Menicon Oculus Private Limited Eye Consultants of Atlanta Sharif Eye Centers Memira
-
-
The launch of 5mm hand activated 90 degree hook and spatula is here!! ArtiSential - Robotically Simple
One advantage you, as a surgeon, have when working with LivsMed is that our ongoing focus on innovation—the foundation of our company—allows you to bring your patients not just proven solutions but the latest advances. In recent months, LivsMed has not only maintained its leadership in laparoscopic instruments but has also introduced our ArtiSential 5 line, making us the sole provider of 5mm wristed articulating instruments. With the approval of our new 5mm Hook and Spatula, you now have reliable monopolar coagulation and dissection capabilities, enabling you to approach your target area from any angle with a full range of motion for even complex maneuvers. Our instruments bring articulation to any O.R., anytime, eliminating the need for dedicated robotic room block time. They can also enhance your robotic procedures, promoting efficiency and cost savings. If you missed seeing our original 8mm ArtiSential line, the new 5mm ArtiSential 5, or our latest innovation, the 5mm Hook and Spatula, at our recent shows, please email infoUSA@livsmed.com or call 619-872-5555. You can discuss these innovations with your area sales representative and arrange a demonstration at your hospital or ASC. #LivsMed #ArtiSential #MIS #laparoscopicsurgery
-
-
We are just over a week away from our Virtual Discussion on Early Stage Ophthalmic Innovation. Can't make it to the live discussion? Anyone registered for the event will receive the recording via email after the conversation. Date: September 18, 2024 Time: 8:00 - 8:45 PM EST Use the link below to register. https://lnkd.in/eytyrbBa #virtualdiscussion #VentureCapital #Investing #Ophthalmology #webinar
-
